Medical group launches £121m acquisition on back of 'pleasing' annual results
Analysts upgrade recommendation to 'Buy' for AMS
Source: thebusinessdesk.com
Stay updated with breaking news from Julie Simmonds. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts upgrade recommendation to 'Buy' for AMS
Drugs discovery firm has a cash runway up to Q3 2024
Shares dropped by more than 25% in early trading
Operator: Thank you for standing by, and welcome to MaxCyte's Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Sterling Exposed to BOE Repricing Risks 1244 GMT - Investors are betting on very aggressive Bank of England interest-rate rises after data showed U.K. core inflation unexpectedly accelerated in April, but sterling looks vulnerable to a potential sc... | 09:07am